- Home
- MEDP vs HST Comparison
MEDP vs HST Comparison
Compare MEDP & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- HST
- Stock Information
- Founded
- MEDP 1992
- HST 1927
- Country
- MEDP United States
- HST United States
- Employees
- MEDP N/A
- HST N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- HST Real Estate Investment Trusts
- Sector
- MEDP Health Care
- HST Real Estate
- Exchange
- MEDP Nasdaq
- HST Nasdaq
- Market Cap
- MEDP 10.5B
- HST 11.9B
- IPO Year
- MEDP 2016
- HST N/A
- Fundamental
- Price
- MEDP $311.23
- HST $14.65
- Analyst Decision
- MEDP Buy
- HST Buy
- Analyst Count
- MEDP 10
- HST 14
- Target Price
- MEDP $373.22
- HST $19.54
- AVG Volume (30 Days)
- MEDP 404.9K
- HST 9.9M
- Earning Date
- MEDP 04-21-2025
- HST 04-30-2025
- Dividend Yield
- MEDP N/A
- HST 6.14%
- EPS Growth
- MEDP 42.23
- HST N/A
- EPS
- MEDP 12.63
- HST 0.99
- Revenue
- MEDP $2,109,054,000.00
- HST $5,691,000,000.00
- Revenue This Year
- MEDP $4.45
- HST $4.76
- Revenue Next Year
- MEDP $9.67
- HST $3.02
- P/E Ratio
- MEDP $24.42
- HST $14.80
- Revenue Growth
- MEDP 11.84
- HST 7.03
- 52 Week Low
- MEDP $289.01
- HST $13.83
- 52 Week High
- MEDP $459.77
- HST $20.73
- Technical
- Relative Strength Index (RSI)
- MEDP 42.63
- HST 40.89
- Support Level
- MEDP $289.01
- HST $13.83
- Resistance Level
- MEDP $331.24
- HST $15.14
- Average True Range (ATR)
- MEDP 9.98
- HST 0.38
- MACD
- MEDP -1.51
- HST 0.00
- Stochastic Oscillator
- MEDP 52.62
- HST 53.59
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.